Video Experimental Relacionado
Updated: May 5, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
15.1K
Diseño racional de una vacuna de múltiples epítopos contra Salmonella typhi a través de la proteómica sustractiva, la
1Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia. as.albutti@qu.edu.sa.
Scientific reports
|September 1, 2025
Resumen
Una nueva vacuna multi-epitopo para Salmonella typhi fue diseñada computacionalmente para combatir la fiebre tifoidea. Este enfoque in silico acelera el desarrollo de la vacuna para una respuesta inmune duradera.
Área de la Ciencia:
- Vacunas y vacunas
- Biología computacional
- Inmunología
Sus antecedentes:
- La fiebre tifoidea, causada por Salmonella Typhi, sigue siendo un importante problema de salud mundial, especialmente en las zonas con mal saneamiento.
- Los tratamientos existentes son insuficientes, lo que pone de relieve la necesidad urgente de vacunas efectivas y duraderas.
- Los plazos actuales de desarrollo de vacunas son largos, lo que requiere enfoques innovadores.
Objetivo del estudio:
- Diseñar una nueva vacuna multiepitópica contra la Salmonella Typhi utilizando una estrategia integrada en silico.
- Identificar las proteínas conservadas, virulentas, antigénicas y no alergénicas de S. Typhi para la selección de candidatos a vacunas.
- Predecir y optimizar los epítopos de las células B y T para mejorar la inmunogenicidad y la eficacia de la vacuna.
Principales métodos:
- Se utilizó la proteómica sustractiva para identificar posibles proteínas diana de la vacuna de 122 cepas de S. Typhi.
- Empleó inmunoinformática para predecir y seleccionar epítopos de células B y células T (HTL y CTL).
- Incorporó beta-defensina-2 humana como adyuvante y utilizó enlaces para el ensamblaje de la construcción de la vacuna, seguido de acoplamiento molecular, dinámica y simulaciones inmunológicas.
Principales resultados:
- Se identificaron tres proteínas clave: la subunidad principal de la curlina, la proteína A de la membrana externa y una proteína hipotética.
- Se seleccionaron cuatro epítopos de células B y diez de células T, combinados con un adyuvante, para formar la construcción final de la vacuna.
- Las simulaciones de acoplamiento molecular y dinámica confirmaron interacciones estables con TLR4, MHC-I y MHC-II, prediciendo una respuesta inmune robusta y duradera.
Conclusiones:
- El enfoque in silico aceleró significativamente el desarrollo de una posible vacuna multi-epítopo contra la fiebre tifoidea.
- El constructo de vacuna diseñado demostró una estabilidad prometedora y el potencial para inducir una respuesta inmune fuerte y duradera.
- Esta tubería computacional ofrece una estrategia viable para el rápido desarrollo de vacunas bacterianas, abordando las necesidades críticas de salud pública.
Palabras clave:
En el caso de la salmonela TyphiProteómica del núcleoSimulación de MDModelado molecularVacuna con varios epítoposProteómica sustractivaLa fiebre tifoideaMás Videos Relacionados
Videos de Conceptos Relacionados
01:26Pharmacokinetic Models: Comparison and Selection Criterion
490
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
01:28Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
363
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363
01:23Dosage Regimen Designs: Nomograms and Tabulations
353
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
353
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
127
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
127
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97